Dr. Zarrabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1025 Walnut Street
Philadelphia, PA 19107
Education & Training
Temple University Hospital-Fox Chase Cancer CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
Stony Brook Medicine/University HospitalChief Residency, Internal Medicine, 2018 - 2019- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 2015 - 2018
St. George's University School of MedicineClass of 2015
Certifications & Licensure
NJ State Medical License 2023 - 2025
PA State Medical License 2019 - 2024
NY State Medical License 2018 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Enhancing the Immunogenicity of Nivolumab plus Ipilimumab with Live Bacterial Supplementation in Metastatic Renal Cell Carcinoma.Kevin K Zarrabi, Ulka Vaishampayan, Pedro C Barata
European Urology Focus. 2025-01-20 - 1 citationsT-Cell redirecting bispecific antibodies: a review of a novel class of immuno-oncology for advanced prostate cancer.Julia Palecki, Amman Bhasin, Andrew Bernstein, Patrick J Mille, William J Tester
Cancer Biology & Therapy. 2024-12-31 - Novel Methods to Assess Tumor Burden and Minimal Residual Disease in Genitourinary Cancers.Pedro C Barata, Kevin K Zarrabi, Axel Bex, Petros Grivas, Ken Hermann
European Urology. 2024-12-04
Press Mentions
Dr. Kevin Zarrabi Talks Treatment of Metastatic Renal Cell CarcinomaJuly 12th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
